home All News open_in_new Full Article

ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial

Experienced hematologist-oncologist to lead strategic and medical oversight of clinical development program SASKATOON, Saskatchewan — ZYUS Life Sciences Corporation (the “Company”) (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, today announced the appointment of Dr. Julie Stakiw, MD, FRCPC, to the Company’s […]


today 9 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Other
attach_file Culture
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Other
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Economics
attach_file Events
attach_file Events
attach_file Economics
attach_file Other
attach_file Events
attach_file Economics


ID: 3018657023
Add Watch Country

arrow_drop_down